Chevron Corporation CVX CEO Flags Inadequate Venezuelan Policy Reforms for NearTerm Production Upside PCSA Processa Pharmaceuticals posts worsethanexpected Q4 2025 EPS results that miss estimates by 68 percent as shares edge 033 percent lower Textron Inc TXT Q1 2026 Earnings Preview Headwinds Offset Modest TopLine Growth Prospects